Tandem Diabetes Care (TNDM) Misses Q3 EPS by 3c

Tandem Diabetes Care (NASDAQ: TNDM) reported Q3 EPS of ($0.85), $0.03 worse than the analyst estimate of ($0.82). Revenue for the quarter came in at $13.5 million versus the consensus estimate of $13.6 million.

For earnings history and earnings-related data on Tandem Diabetes Care (TNDM) click here.

You May Also Be Interested In

• Nvidia pitches Vera CPU to Chinese clients with August delivery target
• Sharon AI surges premarket; New Oriental gains, Medline slips
• UBS Reiterates Neutral Rating on Lennar (LEN) Following Q2 Results